|
There has been little or no change in the methods of treating Dupuytren's disease in recent years. However, we are encouraged by the interest of cellular biologists and collagen chemists who have contributed to our understanding of the disease process. We can anticipate that sufficient knowledge will be gained in the near future so that surgeons can evolve a rational approach to the treatment of Dupuytren's disease.
| 